Literature DB >> 30444067

Irritable bowel syndrome, mental health, and quality of life: Data from a population-based survey in Germany (SHIP-Trend-0).

Birgit Schauer1, Hans J Grabe2, Till Ittermann1, Markus M Lerch3, Frank U Weiss3, Hubert Mönnikes4, Henry Völzke1, Paul Enck5, Juliane Schwille-Kiuntke5.   

Abstract

BACKGROUND: Irritable bowel syndrome (IBS) is associated with reduced quality of life and high healthcare costs. This study aimed to assess the prevalence and risk factors for IBS in a general adult population.
METHODS: The Study of Health in Pomerania (SHIP) is a population-based cohort study in northeastern Germany. SHIP-Trend-0 participants enrolled from 2008 to 2012 were grouped according to Rome III criteria (main criteria: abdominal discomfort or crampy or bloating pain for at least six months plus 2/3 additional criteria). Factors associated with IBS were assessed using survey-weighted backward stepwise logistic regression. KEY
RESULTS: The final data set included 4194 records. IBS prevalence was 3.5% (3.0%-4.2%). Unemployment (OR: 2.02, 1.26-3.21), headaches (OR: 2.37, 1.59-3.52), mental quality of life (OR: 0.95 per unit increase, 0.93-0.97), and interactions between gender and physical quality of life (P = 0.004) and gender and alexithymia (P = 0.002) predicted IBS probability. The model resulted in a good discrimination (area under the curve = 75.4%) and model fit (F = 0.72, P = 0.69). History of depression (OR: 2.77, 1.94-3.95), back pain (OR: 2.38, 1.69-3.35), early trauma (OR: 1.03, 1.02-1.04), and duration of inpatient treatment within the last twelve months (OR: 1.02, 1.01-1.04) lost their significance in multivariable analysis. CONCLUSIONS & INFERENCES: IBS prevalence was relatively low compared to other studies. Factors predicting IBS were of biological, psychological, and social nature. The association between IBS and pain in different areas of the body indicates a potential underlying complex somatic symptom disorder.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  epidemiology; functional GI disorders; irritable bowel syndrome

Mesh:

Year:  2018        PMID: 30444067     DOI: 10.1111/nmo.13511

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  5 in total

1.  The Prevalence, Comorbidity, Management and Costs of Irritable Bowel Syndrome.

Authors:  Winfried Häuser; Ursula Marschall; Peter Layer; Thomas Grobe
Journal:  Dtsch Arztebl Int       Date:  2019-07-08       Impact factor: 5.594

Review 2.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

3.  Exploring Quality of Life, Stress, and Risk Factors Associated with Irritable Bowel Syndrome for Female University Students in Taiwan.

Authors:  Huan-Hwa Chen; Chich-Hsiu Hung; Ai-Wen Kao; Hsiu-Fen Hsieh
Journal:  Int J Environ Res Public Health       Date:  2021-04-07       Impact factor: 3.390

4.  Risk Factors for Self-reported Irritable Bowel Syndrome With Prior Psychiatric Disorder: The Lifelines Cohort Study.

Authors:  Francis Creed
Journal:  J Neurogastroenterol Motil       Date:  2022-07-30       Impact factor: 4.725

5.  Illness perception and health care use in individuals with irritable bowel syndrome: results from an online survey.

Authors:  Juliane Schwille-Kiuntke; Solveig Lu Rüdlin; Florian Junne; Paul Enck; Katja Brenk-Franz; Stephan Zipfel; Monika A Rieger
Journal:  BMC Fam Pract       Date:  2021-07-19       Impact factor: 2.497

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.